Capital World Investors
KRYS icon

Capital World Investors’s Krystal Biotech KRYS Stock Holding History

Capital World Investors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289M Sell
777,843
-46,877
-6% -$14M 0.03% 284
2026
Q1 		$213M Buy
824,720
+15,220
+2% +$4.05M 0.03% 298
2025
Q4 		$200M Buy
809,500
+260
+0% +$54.7K 0.03% 282
2025
Q3 		$143M Sell
809,240
-133,009
-14% -$19.9M 0.02% 311
2025
Q2 		$130M Sell
942,249
-12,219
-1% -$1.79M 0.02% 323
2025
Q1 		$172M Buy
954,468
+75,265
+9% +$12.7M 0.03% 281
2024
Q4 		$138M Buy
879,203
+120
+0% +$21.3K 0.02% 310
2024
Q3 		$160M Buy
879,083
+925
+0.1% +$178K 0.02% 294
2024
Q2 		$161M Buy
878,158
+781,011
+804% +$131M 0.03% 291
2024
Q1 		$17.3M Buy
+97,147
New +$13.5M ﹤0.01% 464

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors's KRYS Position: Q2 2026 in Review

Capital World Investors reduced its Krystal Biotech (KRYS) stake by 5.7% in Q2 2026, selling an estimated $14M and leaving 777,843 shares worth $289M. The position accounts for 0.03% of the portfolio, ranked #284.

Capital World Investors first reported a position in KRYS in Q1 2024 and has held it in 10 quarters since. 328 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Capital World Investors held 777,843 shares of Krystal Biotech worth $289M as of Q2 2026.
  • Capital World Investors sold 46,877 Krystal Biotech shares in Q2 2026, an estimated $14M.
  • Krystal Biotech made up 0.03% of Capital World Investors's portfolio in Q2 2026, its #284 holding.
  • Capital World Investors first reported a position in Krystal Biotech in Q1 2024 and has held it in 10 quarters since.
  • 328 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.